NCT05979675Recruiting
Acute Myeloid Leukemia Registry
Acute Myeloid Leukemia Registry - Prospective National Multicentric Observational Study
Source: ClinicalTrials.gov · Last updated 7 Aug 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
All acute myeloid leukemia (AML) patients diagnosed after 1 Jan 2020 will be included to this study.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 250 (estimated)
- First submitted
- 29 Jul 2023
- Start date
- 21 Dec 2021
- Primary completion date
- 21 Dec 2026
- Lead sponsor
- Turkish Hematology Association
- Diseases
- Acute myeloid leukemia
- NCT number
- NCT05979675
What you commit to
- Study type: Observational
- Planned participants: 250
- From 21 Dec 2021 to the primary completion date, 21 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Patients under 18 years old
Who the study is looking for
- Diagnosed as AML after 1 Jan 2020
- Patients signed informed consent form
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Antalya Training and Research Hospital Coordinator of this site? Confirm its status | Antalya | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.